InspireMD (FRA:II2) Inventory-to-Revenue : 1.13 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is InspireMD Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. InspireMD's Average Total Inventories for the quarter that ended in Dec. 2023 was €1.83 Mil. InspireMD's Revenue for the three months ended in Dec. 2023 was €1.62 Mil. InspireMD's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 1.13.

InspireMD's Inventory-to-Revenue for the quarter that ended in Dec. 2023 increased from Sep. 2023 (1.13) to Sep. 2023 (1.13)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. InspireMD's Days Inventory for the three months ended in Dec. 2023 was 144.99.

Inventory Turnover measures how fast the company turns over its inventory within a year. InspireMD's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.63.

InspireMD Inventory-to-Revenue Historical Data

The historical data trend for InspireMD's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InspireMD Inventory-to-Revenue Chart

InspireMD Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventory-to-Revenue

Get a 7-Day Free Trial

0.32

0.56

0.27

0.26

0.30

InspireMD Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Inventory-to-Revenue	Get a 7-Day Free Trial															1.53	1.35	1.03	1.13	1.13

Competitive Comparison of InspireMD's Inventory-to-Revenue

For the Medical Devices subindustry, InspireMD's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InspireMD's Inventory-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InspireMD's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where InspireMD's Inventory-to-Revenue falls into.

InspireMD Inventory-to-Revenue Calculation

InspireMD's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

	Inventory-to-Revenue (A: Dec. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )
=	( (1.53	+	1.931)	/	2 )	/	5.69
=	1.7305					/	5.69
=	0.30

InspireMD's Inventory-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

	Inventory-to-Revenue (Q: Dec. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Revenue (Q: Dec. 2023 )
=	( (1.73	+	1.931)	/	2 )	/	1.615
=	1.8305					/	1.615
=	1.13

InspireMD (FRA:II2) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

InspireMD's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	1.8305	/	1.152	*	365 / 4
	=	144.99

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

InspireMD's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	1.152	/	1.8305
	=	0.63

InspireMD Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of InspireMD's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

InspireMD (FRA:II2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InspireMD Inc (FRA:II2) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

NSPR:USA

Address

4 Menorat Hamaor Street, Tel Aviv, ISR, 6744832

Website

https://www.inspiremd.com

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.

InspireMD (FRA:II2) Headlines

No Headlines